Disruption of exon definition produces a dominant-negative growth hormone isoform that causes somatotroph death and IGHD II

Human Genetics

Volumn 113, Issue 2, 2003, Pages 140-148

  Ryther, Robin C C ^a   McGuinness, Lindsay M ^b   Phillips III, John A ^c   Moseley, Chanda T ^c   Magoulas, Charalambos B ^d   Robinson, Iain C A F ^b   Patton, James G ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ADENOHYPOPHYSIS; ALTERNATIVE RNA SPLICING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CELL DEATH; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENHANCER REGION; EXON; GENE CONTROL; GENE DISRUPTION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC VARIABILITY; GROWTH HORMONE DEFICIENCY; HORMONE SYNTHESIS; HUMAN; HYPOPLASIA; ISOLATED GROWTH HORMONE DEFICIENCY TYPE 2; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PITUITARY DWARFISM; PRIORITY JOURNAL; SOMATIC CELL; TRANSGENIC MOUSE;

MUS MUSCULUS;

EID: 0037897328     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-003-0949-x     Document Type: Article

References (35)

1. Barnard D, Li J, Peng R, Patton JG (2002) Regulation of alternative splicing by SRrp86 through co-activation and repression of specific SR proteins. RNA 8:526-533
2. Berget SM (1995) Exon recognition in vertebrate splicing. J Biol Chem 270:2411-2414
3. Binder G, Ranke M (1995) Screening for growth hormone (GH) gene splice-site mutations in sporadic cases with severe isolated GH deficiency using ectopic transcript analysis. J Clin Endocrinol Metab 80:1247-52
4. Binder G, Brown M, Parks J (1996) Mechanisms responsible for dominant expression of human growth hormone gene mutations. J Clin Endocrinol Metab 81:4047-50
5. Binder G, Keller E, Mix M, Massa G, Stokvis-Brantsma W, Wit J, Ranke M (2001) Isolated GH deficiency with dominant inheritance: New mutations, new insights. J Clin Endocrinol Metab 86:3877-3881
6. Black DL (1995) Finding splice sites within a wilderness of RNA. RNA 1:763-771
7. Blencowe BJ (2000) Exonic splicing enhancers: Mechanism of action, diversity and role in human genetic disease. Trends Biol Sci 25:106-110
8. Bozzola M, Mengarda F, Sartirana P, Tato L, Chaussain JL (2000) Long-term follow-up evaluation of magnetic resonance imaging in the prognosis of permanent GH deficiency. Eur J Endocrinol 143:493-496
9. Cartegni L, Chew SL, Krainer AR (2002) Listening to silence and understanding nonsense: Exonic mutations that affect splicing. Nat Rev Genet 3:285-298
10. Cogan J, Ramel B, Lehto M, Phillips JA III, Prince M, Blizzard R, De Ravel T, Brammert M, Groop L (1995) A recurring dominant negative mutation causes autosomal dominant growth hormone deficiency - A clinical research center study. J Clin Endocrinol Metab 80:3591-3595
11. Cogan J, Prince M, Lekhakula S, Bundey S, Futrakul A, McCarthy E, Phillips III JA (1997) A novel mechanism of aberrant pre-mRNA splicing in humans. Hum Mol Genet 6:909-912
12. Coolidge CJ, Patton JG (1995) Run-around PCR: A novel way to create duplications using polymerase chain reaction. Biotechniques 18:763-764
13. De Vos A, Ultsch M, Kossiakoff A (1992) Human growth hormone and extracellular domain of its receptor: Crystal structure of the complex. Science 255:306-312
14. Deladoey J, Stocker P, Mullis P (2001) Autosomal dominant GH deficiency due to an Arg183His GH-1 gene mutation: Clinical and molecular evidence of impaired regulated GH secretion. J Clin Endocrinol Metab 86:3941-3947
15. Fofanova O, Evgrafov O, Polyakov A, Polltouraus A, Peterkova V, Dedov I (2000) Molecular heterogeneity of familial isolated growth hormone deficiency, type II: A novel IVS3+2 T→C splicing mutation in the GH-1 gene. Horm Res 53S2:56A
16. Graveley BR, Hertel KJ, Maniatis T (1998) A systematic analysis of the factors that determine the strength of pre-mRNA splicing enhancers. EMBO J 17:6747-6756
17. Graves TK, Patel S, Dannies PS, Hinkle PM (2001) Misfolded growth hormone causes fragmentation of the Golgi apparatus and disrupts endoplasmic reticulum-to-Golgi traffic. J Cell Sci 114:3685-3694
18. Hayashi Y, Kamijo T, Yamamoto M, Ohmori S, Phillips III JA, Ogawa M, Igarashi Y, Seo H (1999a) A novel mutation at the donor splice site of intron 3 of the GH-I gene in a patient with isolated growth hormone deficiency. Growth Horm IGF Res 9:434-437
19. Hayashi Y, Yamamoto M, Ohmori S, Kamijo T, Ogawa M, Seo H (1999b) Inhibition of growth hormone (GH) secretion by a mutant GH-I gene product in neuroendocrine cells containing secretory granules: An implication for isolated GH deficiency inherited in an autosomal dominant manner. J Clin Endocrinol Metab 84:2134-2139
20. Jones B, Monks B, Liebhaber S, Cooke N (1995) The human growth hormone gene is regulated by a multicomponent locus control region. Mol Cell Biol 15:7010-7021
21. Lam B, Hertel K (2002) A general role for splicing enhancers in exon definition. RNA 8:1233-1241
22. Lee M, Wajnrajch M, Kim S, Plotnick L, Wang J, Gertner J, Leibel R, Dannies P (2000) Autosomal dominant growth hormone (GH) deficiency type II: The Del32-71-GH deletion mutant suppresses secretion of wild-type GH*. Endocrinology 141:883-890
23. Magoulas C, McGuinness L, Balthasar N, Carmignac D, Sesay A, Mathers K, Christian H, Candeil L, Bonnefont X, Mollard P, Robinson I (2000) A secreted fluorescent reporter targeted to pituitary growth hormone cells in transgenic mice. Endocrinology 141:4681-9
24. McCarter J, Shaw M, Winer L, Baumann G (1990) The 20,000 Da variant of human growth hormone does not bind to growth hormone receptors in human liver. Mol Cell Endocrinol 73:11-14
25. McGuinness L, Magoulas C, Mathers K, Carmignac D, Manneville J-B, Christian H, Phillips III JA, Robinson ICAF (2003) Autosomal dominant growth hormone deficiency disrupts secretory vesicles: In vitro and in vivo studies in transgenic mice. Endocrinology 144:720-731
26. Missarelli C, Herrera L, Merica V, Carvallo P (1997) Two different 5′ splice site mutations in the growth hormone gene causing autosomal dominant growth hormone deficiency. Hum Genet 101:113-117
27. Moseley C, Mullis P, Prince M, Phillips III JA (2002) An exon splice enhancer mutation causes autosomal dominant GH deficiency. The J Clin Endocrinol Metab 87:847-52
28. Phillips III JA, Cogan J (1994) Genetic basis of endocrine disease. 6. Molecular basis of familial human growth hormone deficiency. J Clin Endocrinol Metab 78:11-6
29. Povey S, Lovering R, Bruford E, Wright M, Lush M, Wain H (2001) The HUGO Gene Nomenclature Committee (HGNC). Hum Genet 109:678-680
30. Procter A, Phillips III JA, Cooper D (1998) The molecular genetics of growth hormone deficiency. Hum Genet 103:255-272
31. Shapiro MB, Senepathy P (1987) RNA splice junctions of different classes of eukaryotes: Sequence statistics and functional implications in gene expression. Nucleic Acids Res 15:7155-7174
32. Smith CWJ, Valcarcel J (2000) Alternative pre-mRNA splicing: The logic of combinatorial control. Trends Biol Sci 25:381-388
33. Stewart T, Clift S, Pitts-Meek S, Martin L, Terrell T, Liggitt D, Oakley H (1992) An evaluation of the functions of the 22-kilodalton (kDa), the 20-kDa, and the N-terminal polypeptide forms of human growth hormone using transgenic mice. Endocrinology 130:405-414
34. Su Y, Liebhaber SA, Cooke NE (2000) The human growth hormone gene cluster locus control region supports position-independent pituitary- and placenta-specific expression in the transgenic mouse. J Biol Chem 275:7902-7909
35. Wada M, Uchida H, Ikeda M, Tsunekawa B, Naito N, Banba S, Tanaka E, Hashimoto Y, Honjo M (1998) The 20-kilodalton (kDa) human growth hormone (hGH) differs from the 22-kDa hGH in the complex formation with cell surface hGH receptor and hGH-binding protein circulating in human plasma. Mol Endocrinol 12:146-156